Literature DB >> 10759620

Dyspepsia workload in urban general practice and implications of the British Society of Gastroenterology Dyspepsia guidelines (1996).

K Bodger1, P G Eastwood, S I Manning, M J Daly, R V Heatley.   

Abstract

AIM: To define the characteristics of patients consulting with active dyspeptic symptoms in urban general practice, and to consider the implications of applying the British Society of Gastroenterology Dyspepsia management guidelines.
DESIGN: Prospective observational study over a period of 12 months.
SETTING: Two multipartner, two-centre general practices in the City of Leeds (UK) with a combined target population of 11 011 registered patients.
SUBJECTS: A total of 340 patients consulting with active dyspeptic symptoms (52% male; mean age 53 years, range 16-89 years).
RESULTS: Of the practice population, 3% consulted with dyspepsia (first-time consulter: 19%; previous consulter not yet investigated: 30%; previously investigated: 51%). Of 168 undiagnosed patients, 43% had upper abdominal pain (dysmotility-like symptoms in 42%), 35% had reflux symptoms, 22% had mixed symptoms, 12% had 'alarm' symptoms and 18% had a history of NSAID use. Patients < 45 years old with simple dyspepsia accounted for 32% of undiagnosed cases. A fifth of the workload was in dealing with undiagnosed dyspeptics over 45 years old. One per cent of the population would require endoscopy if all undiagnosed cases either > 45 years or with complicated dyspepsia were investigated. Of 172 previously investigated patients, 29% had negative tests, 25% had 'minor' findings, and 45% had evidence of acid-peptic disease. Patients with duodenal ulcer disease accounted for 12% of the total workload.
CONCLUSIONS: A knowledge of the characteristics of patients consulting with dyspepsia in primary care should allow the adaptation of guidelines, to ensure advice is relevant to local case mix and compatible with local resources.

Entities:  

Mesh:

Year:  2000        PMID: 10759620     DOI: 10.1046/j.1365-2036.2000.00728.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  16 in total

1.  Limited impact on endoscopy demand from a primary care based 'test and treat' dyspepsia management strategy: the results of a randomised controlled trial.

Authors:  Ian S Shaw; Roland M Valori; André Charlett; Cliodna A M McNulty
Journal:  Br J Gen Pract       Date:  2006-05       Impact factor: 5.386

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

3.  Predictive value of alarm features in a rapid access upper gastrointestinal cancer service.

Authors:  N Kapoor; A Bassi; R Sturgess; K Bodger
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

4.  Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease.

Authors:  Dyfrig A Hughes; Keith Bodger; Peter Bytzer; Dirk de Herdt; Dominique Dubois
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.

Authors:  J Hammer; G D Eslick; S C Howell; E Altiparmak; N J Talley
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 6.  Role of symptoms in diagnosis and outcome of gastric cancer.

Authors:  Giovanni Maconi; Gianpiero Manes; Gabriele-Bianchi Porro
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

7.  A Simple Pre-endoscopy Score for Predicting Risk of Malignancy in Patients with Dyspepsia: A 5-Year Prospective Study.

Authors:  Amit Kumar Dutta; Grace Rebekah; Sudipta Dhar Chowdhury; Sajith Kattiparambil Gangadharan; Yuvaraj Subramani; Manoj Kumar Sahu; Reuben Thomas Kurien; Deepu David; Ebby George Simon; Anjilivelil Joseph Joseph; Viswanath Reddy Donapati; Ashok Chacko
Journal:  Dig Dis Sci       Date:  2018-08-14       Impact factor: 3.199

8.  The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States.

Authors:  Douglas Mapel; Melissa Roberts; Andrew Overhiser; Andrew Mason
Journal:  Helicobacter       Date:  2012-09-04       Impact factor: 5.753

9.  Impact of route to diagnosis on treatment intent and 1-year survival in patients diagnosed with oesophagogastric cancer in England: a prospective cohort study.

Authors:  Thomas R Palser; David A Cromwell; Richard H Hardwick; Stuart A Riley; Kimberley Greenaway; Jan H P van der Meulen
Journal:  BMJ Open       Date:  2013-02-13       Impact factor: 2.692

10.  The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case-control study using electronic records.

Authors:  S Stapley; T J Peters; R D Neal; P W Rose; F M Walter; W Hamilton
Journal:  Br J Cancer       Date:  2012-12-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.